Login
Companies $BDSX
$9.00 +$0.00 (0.0%) After hours
BIODESIX INC logo

BIODESIX INC

biodesix.com

What Do They Do?

Sells blood-based lung diagnostic tests to healthcare providers and provides diagnostic testing and development services to biopharmaceutical, life sciences, and diagnostic companies.

How Do They Make Money?

Healthcare payers, medical facilities, insurers, or patients are billed for lung tests when results are delivered. Development clients pay for testing and scientific services when results or milestones are delivered, or over the contract term.

revenue
SegmentShareRevenue
Diagnostic Tests
Sold outright

89%
FY2022: 90%
Development Services
Mix

11%

Who Are Their Customers?

Healthcare providers order blood-based lung tests for patients; fees are billed to third-party payers, medical facilities, commercial insurers, or patients. Biopharmaceutical, life sciences, diagnostic, and academic research organizations use its development and testing services.

Do Revenues Turn Into Profits?

No. It lost $35.3M in FY2025.

Operating income, FY2025
−31% of revenue
▲ +19% (Loss) vs FY2024 (−$34.5M, −48%)
Net income, FY2025
−40% of revenue
▲ +18% (Loss) vs FY2024 (−$42.9M, −60%)
Free cash flow, FY2025
−27% of revenue
▲ +55% (Loss) vs FY2024 (−$51.9M, −73%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +10%
vs $21.8M in Q3 FY2025
Net income
▲ +8% (Loss)
vs −$8.7M in Q3 FY2025
Diagnostic Tests share of revenue vs 91.1% in Q3 FY2025
  • Aug 5, 2026 Maintained full-year 2026 revenue guidance The outlook is $108-114 million, with the midpoint representing approximately 25% growth over 2025.

Growing. Revenue grew 62% in 4 years, from $54.5M in FY2021 to $88.5M in FY2025, about 13% a year.

Pandemic testing The earlier report includes pandemic testing among its diagnostic services; the latest describes diagnostic testing as blood-based lung tests and identifies development services as the other revenue source.

Revenue over time
Diagnostic Tests Development Services Services Biopharma Services and Other Lung Diagnostic Testing
$100M$50M$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support